Literature DB >> 26858214

Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.

Samantha J Broyd1, Hendrika H van Hell1, Camilla Beale1, Murat Yücel2, Nadia Solowij3.   

Abstract

Cannabis use has been associated with impaired cognition during acute intoxication as well as in the unintoxicated state in long-term users. However, the evidence has been mixed and contested, and no systematic reviews of the literature on neuropsychological task-based measures of cognition have been conducted in an attempt to synthesize the findings. We systematically review the empirical research published in the past decade (from January 2004 to February 2015) on acute and chronic effects of cannabis and cannabinoids and on persistence or recovery after abstinence. We summarize the findings into the major categories of the cognitive domains investigated, considering sample characteristics and associations with various cannabis use parameters. Verbal learning and memory and attention are most consistently impaired by acute and chronic exposure to cannabis. Psychomotor function is most affected during acute intoxication, with some evidence for persistence in chronic users and after cessation of use. Impaired verbal memory, attention, and some executive functions may persist after prolonged abstinence, but persistence or recovery across all cognitive domains remains underresearched. Associations between poorer performance and a range of cannabis use parameters, including a younger age of onset, are frequently reported. Little further evidence has emerged for the development of tolerance to the acutely impairing effects of cannabis. Evidence for potential protection from harmful effects by cannabidiol continues to increase but is not definitive. In light of increasing trends toward legalization of cannabis, the knowledge gained from this body of research needs to be incorporated into strategies to minimize harm.
Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Attention; Brain; Cannabis; Cognition; Executive function; Memory

Mesh:

Substances:

Year:  2015        PMID: 26858214     DOI: 10.1016/j.biopsych.2015.12.002

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  173 in total

1.  THC and CBD blood and brain concentrations following daily administration to adolescent primates.

Authors:  S L Withey; J Bergman; M A Huestis; S R George; B K Madras
Journal:  Drug Alcohol Depend       Date:  2020-06-18       Impact factor: 4.492

2.  Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.

Authors:  L Cinnamon Bidwell; Jarrod M Ellingson; Hollis C Karoly; Sophie L YorkWilliams; Leah N Hitchcock; Brian L Tracy; Jost Klawitter; Cristina Sempio; Angela D Bryan; Kent E Hutchison
Journal:  JAMA Psychiatry       Date:  2020-08-01       Impact factor: 21.596

3.  Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies.

Authors:  Jacqueline C Duperrouzel; Karen Granja; Ileana Pacheco-Colón; Raul Gonzalez
Journal:  J Dual Diagn       Date:  2019-06-22

4.  Do Differences in Learning Performance Precede or Follow Initiation of Marijuana Use?

Authors:  Olivier J Barthelemy; Mark A Richardson; Timothy C Heeren; Clara A Chen; Jane M Liebschutz; Leah S Forman; Howard J Cabral; Deborah A Frank; Ruth Rose-Jacobs
Journal:  J Stud Alcohol Drugs       Date:  2019-01       Impact factor: 2.582

5.  Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood.

Authors:  Yan Jouroukhin; Xiaolei Zhu; Alexey V Shevelkin; Yuto Hasegawa; Bagrat Abazyan; Atsushi Saito; Jonathan Pevsner; Atsushi Kamiya; Mikhail V Pletnikov
Journal:  Biol Psychiatry       Date:  2018-08-16       Impact factor: 13.382

Review 6.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

7.  Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.

Authors:  Dustin C Lee; Nicolas J Schlienz; Erica N Peters; Robert H Dworkin; Dennis C Turk; Eric C Strain; Ryan Vandrey
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

Review 8.  A Patient-Tailored Evidence-Based Approach for Developing Early Neuropsychological Training Programs in Addiction Settings.

Authors:  Benjamin Rolland; Fabien D'Hondt; Solène Montègue; Mélanie Brion; Eric Peyron; Julia D'Aviau de Ternay; Philippe de Timary; Mikaïl Nourredine; Pierre Maurage
Journal:  Neuropsychol Rev       Date:  2019-01-03       Impact factor: 7.444

9.  Urinary tetrahydrocannabinol is associated with poorer working memory performance and alterations in associated brain activity.

Authors:  Max M Owens; Shannon McNally; Tashia Petker; Michael T Amlung; Iris M Balodis; Lawrence H Sweet; James MacKillop
Journal:  Neuropsychopharmacology       Date:  2018-10-10       Impact factor: 7.853

10.  Altered Corticolimbic Control of the Nucleus Accumbens by Long-term Δ9-Tetrahydrocannabinol Exposure.

Authors:  Eun-Kyung Hwang; Carl R Lupica
Journal:  Biol Psychiatry       Date:  2019-08-06       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.